Ki67 Recombinant Rabbit Monoclonal Antibody [PSH0-02] (HA721254)

UNIPROT #

P46013

PROTEIN NAME

Ki67

SYNONYMS

Antigen identified by monoclonal antibody Ki 67 antibody;Antigen identified by monoclonal antibody Ki-67 antibody;Antigen KI-67 antibody;Antigen KI67 antibody;Antigen Ki67 antibody;KI67_HUMAN antibody;KIA antibody;Marker of proliferation Ki-67 antibody;MIB 1 antibody;MIB antibody;MKI67 antibody;PPP1R105 antibody;Proliferation marker protein Ki-67 antibody;Proliferation related Ki 67 antigen antibody;Protein phosphatase 1 regulatory subunit 105 antibody;RP11-380J17.2 antibody

SUBCELLULAR LOCATION

Chromosome, Nucleus, nucleolus.

FUNCTION

Antigen KI-67, also known as Ki-67, Ki-67 or MKI67 (Marker Of Proliferation Ki-67), is a protein that in humans is encoded by the MKI67 gene (antigen identified by monoclonal antibody Ki-67). Antigen KI-67 is a nuclear protein that is associated with cellular proliferation. Altering Ki-67 expression levels did not significantly affect cell proliferation in vivo. Ki-67 mutant mice developed normally and cells lacking Ki-67 proliferated efficiently. Furthermore, it is associated with ribosomal RNA transcription. Inactivation of antigen KI-67 leads to inhibition of ribosomal RNA synthesis. The Ki-67 protein (also known as MKI67) is a cellular marker for proliferation, and can be used in immunohistochemistry. It is strictly associated with cell proliferation. During interphase, the Ki-67 antigen can be exclusively detected within the cell nucleus, whereas in mitosis most of the protein is relocated to the surface of the chromosomes. Ki-67 protein is present during all active phases of the cell cycle (G1, S, G2, and mitosis), but is absent in resting (quiescent) cells (G0). Cellular content of Ki-67 protein markedly increases during cell progression through S phase of the cell cycle. In breast cancer Ki67 identifies a high proliferative subset of patients with ER-positive breast cancer who derive greater benefit from adjuvant chemotherapy. Ki-67 is an excellent marker to determine the growth fraction of a given cell population. The fraction of Ki-67-positive tumor cells (the Ki-67 labeling index) is often correlated with the clinical course of cancer. The best-studied examples in this context are prostate, brain and breast carcinomas, as well as nephroblastoma and neuroendocrine tumors. For these types of tumors, the prognostic value for survival and tumor recurrence have repeatedly been proven in uni- and multivariate analysis.